Malaria and the problem of drug resistant Plasmodium falciparum

Please use this identifier to cite or link to this item: http://adhlui.com.ui.edu.ng/jspui/handle/123456789/4367

Full metadata record

DC Field	Value	Language
dc.contributor.author	WALKER, O.	-
dc.date.accessioned	2025-05-29T13:40:23Z	-
dc.date.available	2025-05-29T13:40:23Z	-
dc.date.issued	1993-03	-
dc.identifier.citation	Afr. J. Med. Med. Sci. (1993) 22, 1 - 3	en_US
dc.identifier.issn	1116-4077	-
dc.identifier.uri	http://adhlui.com.ui.edu.ng/jspui/handle/123456789/4367	-
dc.description	Article	en_US
dc.description.abstract	The optimism which greeted the malaria control activities of the sixties has been replaced by pessimism [ 1 ]. There has been a resurgence of the disease as it affects 102 countries, with an estimated 270 million cases and approximately one million deaths annually. Ninety per cent of these deaths come from Africa south of the Sahara [1] making it mainly an African problem. The background to this scenario is the increasing prevalence of drug-resistant P. falciparum [2]. The resultant effect has been increased morbidity and mortality from malaria	en_US
dc.description.sponsorship	College of Medicine, University of Ibadan	en_US
dc.language.iso	en	en_US
dc.subject	Malaria control	en_US
dc.subject	Morbidity	en_US
dc.subject	Mortality	en_US
dc.subject	Malaria	en_US
dc.title	Malaria and the problem of drug resistant Plasmodium falciparum	en_US
dc.type	Article	en_US
Appears in Collections:	African Journal of Medicine and Medical Sciences

Files in This Item:

File	Description	Size	Format
Walker_Malaria_1993.pdf	Article	6.08 MB	Adobe PDF	View/Open

COMUI (ADHL)